AFib-treating cardiac ablation has been a standout performer for Medtronic, with strong commercial demand for the Affera ...

Kevin Lobo is ending a more than 14-year tenure that saw him guide Stryker through dozens of acquisitions that helped the ...

Rhevera Medical represents a clear commitment to the physicians who take on difficult vascular cases and to the patients who ...

Rhythm announced this week that it has completed its $287.5 million acquisition of cardiac monitoring tech company ...

The FDA approved Abbott's plan to allow heart failure patients to view pulmonary artery readings and receive personalized ...

The first-of-its-kind valve is designed with the ability to expand as the child grows, reducing the need for repeat ...

Siemens Healthineers will assist with the manufacturing and marketing of Truvian's TruVerus benchtop blood test analyzer.

The goal is to obtain last-mile logistics for radioactive agents with a short half-life that need to be made as close to patients as possible.

Cook Medical led the financing round, and signed up to exclusively distribute Zenflow's minimally invasive Spring implant.

Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.

Oura is now citing market uncertainty, shortly after outlining plans to raise as much as $2.2 billion on a $15 billion ...

The In.Pact BTK is slated for a pivotal trial of about 400 people with peripheral artery disease in the lower legs facing ...